切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2019, Vol. 13 ›› Issue (02) : 131 -134. doi: 10.3877/cma.j.issn.1674-3903.2019.02.011

所属专题: 经典病例 文献

论著

双肺移植30例临床分析
张真榕1, 梁朝阳2, 马千里1, 余其多1, 苏昆松1, 赵丽3, 陈文慧3, 陈静瑜2,()   
  1. 1. 100029 北京,中日友好医院胸外科
    2. 100029 北京,中日友好医院胸外科;100029 北京,中日友好医院肺移植科
    3. 100029 北京,中日友好医院肺移植科2
  • 收稿日期:2018-11-07 出版日期:2019-05-25
  • 通信作者: 陈静瑜
  • 基金资助:
    中央高校基本科研业务费项目(3332018172)

Clinical analysis of 30 bilateral lung transplantation recipients

zhenrong Zhang1, Chaoyang Liang2, Qianli Ma1, Qiduo Yu1, Kunsong Su1, Li Zhao3, Wenhui Chen3, Jingyu Chen2,()   

  1. 1. Department of General Thoracic Surgery, China Japan Friendship Hospital, Beijing 100029, China
    2. Department of General Thoracic Surgery, China Japan Friendship Hospital, Beijing 100029, China; Department of General Lung Transplant, China Japan Friendship Hospital, Beijing 100029, China
    3. Department of General Lung Transplant, China Japan Friendship Hospital, Beijing 100029, China
  • Received:2018-11-07 Published:2019-05-25
  • Corresponding author: Jingyu Chen
  • About author:
    Corresponding author: Chen Jingyu. Email:
引用本文:

张真榕, 梁朝阳, 马千里, 余其多, 苏昆松, 赵丽, 陈文慧, 陈静瑜. 双肺移植30例临床分析[J/OL]. 中华移植杂志(电子版), 2019, 13(02): 131-134.

zhenrong Zhang, Chaoyang Liang, Qianli Ma, Qiduo Yu, Kunsong Su, Li Zhao, Wenhui Chen, Jingyu Chen. Clinical analysis of 30 bilateral lung transplantation recipients[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2019, 13(02): 131-134.

目的

探究双肺移植手术安全性并分析影响受者短期预后的危险因素。

方法

回顾性分析中日友好医院胸外科2017年4月至2018年6月30例行双肺移植供、受者临床资料。根据术后90 d受者生存情况,将其分为存活组(22例)和死亡组(8例)。采用成组t检验比较两组供肺获取前供者氧合指数、受者年龄和体质指数、供/受者体表面积差、左/右供肺冷缺血时间、手术时间、术中失血量和输液量。采用Wilcoxon符号秩和检验比较两组受者术中输血量和尿量。采用χ2检验比较供者感染情况、受者性别、原发病、术前感染情况及是否使用呼吸机和体外膜肺氧合(EMCO)、双肺移植顺序、术中是否输血和使用EMCO以及术后是否出现吻合口瘘。P<0.05为差异有统计学意义。

结果

30例供者供肺获取前病原学培养阳性19例,其中单一感染14例,混合感染5例。30例双肺移植受者术前病原学培养阳性16例,其中单一感染12例,混合感染4例。30例受者中11例先行左侧单肺移植,19例先行右侧单肺移植。30例受者术后90 d受者死亡比例为26.7%(8/30),死亡原因包括感染中毒性休克4例及吻合口瘘、大咯血、循环功能衰竭和活动性出血各1例。短期预后危险因素分析提示,死亡组和存活组受者术中输血量分别为900 mL(0~6 450 mL)和25 mL(0~1 450 mL),差异有统计学意义(z=-2.524,P<0.05)。

结论

双肺移植围手术期死亡率较低,受者术中输血量可能影响移植术后受者存活率。

Objective

To evaluate the safety of bilateral lung transplantation and its relative risk factors at short-term follow-up.

Methods

The clinical data of 30 bilateral lung transplantation recipients who got transplantation in China Japan Friendship Hospital from April 2017 to June 2018 were retrospectively analysed. The recipients were divided into 2 groups according to the survival condition at 90 days after transplantation, 22 recipients were grouped into survival group, and the rest were grouped into death group. Indexes including oxygenation index, age and body index of recipient, difference of body surface area between donor and recipient, cold ischemia duration of donor lungs, operation duration, intraoperative blood loss and infusion between the two groups were compared with independent t test. The volume of blood transfusion and urinary amount during transplantation were compared with Wilcoxon rank sum test. Infectious status of donor, and gender, primary disease, preoperative infectious status, utilization of respirator and extracorporeal membrane oxygenation (ECMO) before operation, sequence of transplantation, transfusion and utilization of ECMO during operation, and anastomotic fistula after operation between the 2 groups were compared with chi-square test. P<0.05 means statistically significant.

Results

Among 30 donors, 19 cases showed positive etiology preoperatively, including 14 cases of single infection and 5 cases of mixed infection. 16 recipients showed positive etiology preoperatively, including 12 cases of single infection and 4 cases of mixed infection. Left lung transplant were performed preferentially in 11 cases, whereas right lung transplant were performed preferentially in 19 cases. Eight recipients died [26.7% (8/30)] during their postoperative 90 days, 4 recipients died of toxic shock. The other 4 recipients died of broncho-bronchus anastomosis fistula, massive hemoptysis, circulation function failure and active bleeding, respectively. The result of the risk factors influencing the short-term prognosis of recipients showed that the blood transfusion volume of survival group and death group were 900 mL (0~6 450 mL) and 25 mL (0~1 450 mL) respectively, which had statistical significance (z=-2.524, P<0.05).

Conclusions

Perioperative mortality of bilateral lung transplant was acceptable. The blood transfusion volume during transplantation could influence the survival rate of recipients at short-term follow-up.

表1 双肺移植受者术后短期预后危险因素分析
组别 例数 供者因素 受者因素
病原学培养阳性(例) 氧合指数(±s,mmHg) 性别(男/女,例) 年龄(±s,岁) BMI(±s,kg/m2) 供/受者体表面积差(±s,m2)
死亡组 8 4 431±75 5/3 44±15 19±4 0.26±0.19
存活组 22 15 445±62 18/4 54±13 20±4 0.29±0.21
χ2/t/z 0.835 -0.527 1.224 -1.829 -0.377 -0.214
P >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
组别 例数 受者因素
病原学培养阳性(例) 原发病(例) 术前使用呼吸机(例)
特发性肺间质纤维化 慢性阻塞性肺疾病 支气管扩张 其他
死亡组 8 6 2 0 3 3 2
存活组 22 10 6 9 3 4 7
χ2/t/z 2.058 5.893 0.130
P >0.05 >0.05 >0.05
组别 例数 受者因素
术前使用ECMO(例) 移植顺序(先右/先左,例) 右供肺冷缺血时间(±s,min) 左供肺冷缺血时间(±s,min) 手术时间(±s,min)
死亡组 8 1 5/3 288±148 316±119 369±70
存活组 22 1 14/8 300± 67 342±148 355±69
χ2/t/z 0.597 0.003 -0.308 -0.439 0.481
P >0.05 >0.05 >0.05 >0.05 >0.05
组别 例数 受者因素
术中出血量(±s,mL) 术中输血(例) 术中输血量[M(minmax),mL] 术中输液量(±s,mL) 术中尿量[M(minmax),mL] 术中使用ECMO(例) 术后发生吻合口瘘(例)
死亡组 8 944±675 7 900(0~6 450) 3 006±2 525 400(30~ 700) 5 1
存活组 22 816±788 11 25(0~1 450) 2 456± 875 375(50~3 100) 9 2
χ2/t/z 0.407 3.438 -2.524 0.905 -0.540 1.099 0.076
P >0.05 >0.05 <0.05 >0.05 >0.05 >0.05 >0.05
1
Yusen RD, Edwards LB, Dipchand AI, et al. The registry of the international society for heart and lung transplantation: thirty-third adult lung and heart-lung transplant report-2016; focus theme: primary diagnostic indications for transplant[J]. J Heart Lung Transplant, 2016, 35(10): 1170-1184.
2
Mason DP, Rajeswaran J, Li L, et al. Effect of changes in postoperative spirometery on survival after lung transplantation[J]. J Thorac Cardiovasc Surg, 2012, 144(1): 197-203.
3
Genao L, Whitson HE, Zaas D, et al. Functional status after lung transplantation in older adults in the post-allocation score era[J]. Am J Transplant, 2013, 13(1): 157-166.
4
王振兴,陈静瑜,郑明峰,等. 肺移植供肺获取100例:冷缺血时间>6 h及肺减容对预后的影响[J]. 中国组织工程研究与临床康复,2012, 16(5): 835-838.
5
Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: 29th adult lung and heart-lung transplant report-2012[J]. J Heart Lung Transplant, 2012, 31(10): 1073-1086.
6
轩永波,潘禹辰,展宇飞,等. 公民逝世后器官捐献供肺评估标准和维护经验[J]. 中华器官移植杂志,2016, 37(1): 39-41.
7
Snell GI, Griffiths A, Levvey BJ, et al. Availability of lungs for transplantation: exploring the real potential of the donor pool[J]. J Heart Lung Transplant, 2008, 27(6): 662-667.
8
Cypel M, Keshavjee S. Extracorporeal life support as a bridge to lung transplantation[J]. Clin Chest Med, 2011, 32(2): 245-251.
9
Hayanga JA, Lira A, Vlahu T, et al. Procedural volume and survival after lung transplantation in the United States: the need to look beyond volume in the establishment of quality metrics[J]. Am J Surg, 2016, 211(4): 671-676.
10
Mitchell AB. The lung microbiome and transplantation[J]. Curr Opin Organ Transplant, 2019, 24(3): 305-310.
11
Ong LP, Thompson E, Sachdeva A, et al. Allogeneic blood transfusion in bilateral lung transplantation: impact on early function and mortality[J]. Eur J Cardiothorac Surg, 2016, 49(2): 668-674.
12
Ong LP, Sachdeva A, Ramesh BC, et al. Lung transplant with cardiopulmonary bypass: impact of blood transfusion on rejection, function, and late mortality[J]. Ann Thorac Surg, 2016, 101(2): 512-519.
13
Andreu G, Boudjedir K, Muller JY, et al. Analysis of transfusion-related acute lung injury and possible transfusion-related acute lung injury reported to the french hemovigilance network from 2007 to 2013[J]. Transfus Med Rev, 2018, 32(1): 16-27.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[6] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[7] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[8] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[9] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[10] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[11] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[12] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[13] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[14] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要